2025 annual financial data
Innate Pharma 2025 Operating margin
Direct answer
Operating margin was -1,916.94%.
Operating income was -53,425,000 EUR and net income was -49,177,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,787,000 EUR
- Operating income
- -53,425,000 EUR
- Net income
- -49,177,000 EUR
- Operating cash flow
- Not available